Forte Biosciences Inc (FBRX)

$33.87 +7.60 (28.93%)
Market Cap 363.40M
Revenue (ttm) 0.00
Net Income (ttm) -69.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,772,697
Avg Vol 225,096
Day's Range N/A - N/A
Shares Out 13.89M
Stochastic %K 48%
Beta 3.20
Analysts Strong Sell
Price Target $63.75

Company Profile

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Industry: Biotechnology
Sector: Healthcare
Phone: 310 618 6994
Address:
3060 Pegasus Park Drive, Building 6, Dallas, United States
CrowNightfall
CrowNightfall Apr. 9 at 4:54 PM
$GLMD $ELAB $FBRX $LUD ~03
0 · Reply
_AstralRaven
_AstralRaven Apr. 9 at 4:27 PM
$STAA $FBRX $IVVD $FMFC :1:
0 · Reply
Reacting
Reacting Apr. 9 at 4:15 PM
Ticker NXTS is squeezing!! NXTS 397k shares only!! Will NXTS be the next AIXI 2.0 ticker?! Short liquidation on NXTS right now!! $CHOW $LUD $FBRX $ANTA %
0 · Reply
LewisDaKat
LewisDaKat Apr. 9 at 4:00 PM
$FBRX Forte Biosciences Inc. (NASDAQ: FBRX) Rises Sharply in 4/9 Early Trading Session https://marketwirenews.com/stock/fbrx/news/forte-biosciences-inc-nasdaq-fbrx-rises-sharply-in-4-7062459549742409.html?utm_source=stocktwits
0 · Reply
AstralRaven
AstralRaven Apr. 9 at 4:00 PM
$ELAB $FBRX $ANTA $GIPR %100
0 · Reply
MaxDomain
MaxDomain Apr. 9 at 3:57 PM
$OMEX Save your breath, don`t buy this shitty stock, it will never go beyond 3$. Delisting coming soon $AFJK $FBRX $STAA $ANTA
2 · Reply
MaxDomain
MaxDomain Apr. 9 at 3:45 PM
$OMEX here is another pumpy dumpy stock ladies and gentlemen $AFJK $FBRX $CYCN $STAA
0 · Reply
Astrid00
Astrid00 Apr. 9 at 3:44 PM
$FBRX $PMAX $PSTV $TMDE $VWAV let’s go
0 · Reply
Reacting
Reacting Apr. 9 at 3:36 PM
$FBRX $ELAB $CLIK moving!
0 · Reply
Reacting
Reacting Apr. 9 at 3:36 PM
$GLMD $FBRX $NVDA $TSLA xS
0 · Reply
Latest News on FBRX
Forte Biosciences Announces Pricing of $150 Million Public Offering

Apr 8, 2026, 9:30 PM EDT - 15 hours ago

Forte Biosciences Announces Pricing of $150 Million Public Offering

Forte Biosciences Announces Proposed Public Offering

Apr 8, 2026, 4:02 PM EDT - 20 hours ago

Forte Biosciences Announces Proposed Public Offering

Forte Biosciences, Inc. Announces 2025 Results and Provides Update

Mar 31, 2026, 4:01 PM EDT - 8 days ago

Forte Biosciences, Inc. Announces 2025 Results and Provides Update

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Mar 17, 2026, 4:01 PM EDT - 22 days ago

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

Mar 4, 2026, 4:01 PM EST - 5 weeks ago

Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Feb 9, 2026, 4:01 PM EST - 2 months ago

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Dec 22, 2025, 4:01 PM EST - 3 months ago

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update

Nov 14, 2025, 9:00 AM EST - 5 months ago

Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update

Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

Nov 3, 2025, 4:01 PM EST - 5 months ago

Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium

Sep 15, 2025, 9:00 AM EDT - 7 months ago

Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium

Forte Biosciences, Inc. Announces Results and Provides Update

Aug 14, 2025, 4:01 PM EDT - 8 months ago

Forte Biosciences, Inc. Announces Results and Provides Update

Forte Biosciences Announces Pricing of $75 Million Public Offering

Jun 25, 2025, 12:28 AM EDT - 10 months ago

Forte Biosciences Announces Pricing of $75 Million Public Offering

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

Jun 23, 2025, 7:18 AM EDT - 10 months ago

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Mar 31, 2025, 9:00 AM EDT - 1 year ago

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Forte Biosciences to Host R&D Day December 3, 2024

Nov 25, 2024, 9:00 AM EST - 1 year ago

Forte Biosciences to Host R&D Day December 3, 2024

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Nov 20, 2024, 9:00 AM EST - 1 year ago

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

Nov 14, 2024, 4:01 PM EST - 1 year ago

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

May 13, 2024, 4:05 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Mar 18, 2024, 4:05 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Nov 13, 2023, 4:01 PM EST - 2 years ago

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual Meeting

Sep 14, 2023, 10:50 AM EDT - 2 years ago

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual Meeting

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company's Boardroom

Sep 6, 2023, 3:15 PM EDT - 2 years ago

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company's Boardroom

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Aug 14, 2023, 4:01 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102

Aug 1, 2023, 4:01 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102

Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

May 15, 2023, 4:01 PM EDT - 3 years ago

Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Mar 31, 2023, 4:05 PM EDT - 3 years ago

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Jan 12, 2023, 4:05 PM EST - 3 years ago

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Nov 14, 2022, 4:01 PM EST - 3 years ago

Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Nov 14, 2022, 4:01 PM EST - 3 years ago

Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Camac Partners Condemns Forte Biosciences' Seemingly Defensive and Unjustifiable Capital Raise

Aug 17, 2022, 8:00 AM EDT - 3 years ago

Camac Partners Condemns Forte Biosciences' Seemingly Defensive and Unjustifiable Capital Raise

Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Aug 15, 2022, 4:05 PM EDT - 3 years ago

Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President

Jun 7, 2022, 9:00 AM EDT - 4 years ago

Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President

Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update

May 16, 2022, 9:00 AM EDT - 4 years ago

Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Sep 6, 2021, 12:42 PM EDT - 4 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Why Forte Biosciences Stock Is Down Over 80% Today

Sep 3, 2021, 2:31 PM EDT - 4 years ago

Why Forte Biosciences Stock Is Down Over 80% Today

A small biotech firm just plummeted 82% after abandoning a drug candidate due to failed phase 2 trial

Sep 3, 2021, 12:19 PM EDT - 4 years ago

A small biotech firm just plummeted 82% after abandoning a drug candidate due to failed phase 2 trial

Forte Biosciences stock plunges more than 80% after 'disappointing' trial results of atopic dermatitis treatment

Sep 3, 2021, 7:21 AM EDT - 4 years ago

Forte Biosciences stock plunges more than 80% after 'disappointing' trial results of atopic dermatitis treatment

Forte Biosciences Just Plummeted 80%: Here's Why

Sep 2, 2021, 5:47 PM EDT - 4 years ago

Forte Biosciences Just Plummeted 80%: Here's Why

Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance

Sep 2, 2021, 4:05 PM EDT - 4 years ago

Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance

Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7

Aug 16, 2021, 4:05 PM EDT - 5 years ago

Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7

Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update

May 10, 2021, 4:05 PM EDT - 5 years ago

Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update

Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update

May 3, 2021, 4:30 PM EDT - 5 years ago

Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update

Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update

Mar 24, 2021, 8:00 AM EDT - 5 years ago

Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update

Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update

Mar 17, 2021, 4:05 PM EDT - 5 years ago

Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update

Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th

Feb 23, 2021, 4:01 PM EST - 5 years ago

Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th

Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1st

Feb 18, 2021, 4:01 PM EST - 5 years ago

Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1st

CrowNightfall
CrowNightfall Apr. 9 at 4:54 PM
$GLMD $ELAB $FBRX $LUD ~03
0 · Reply
_AstralRaven
_AstralRaven Apr. 9 at 4:27 PM
$STAA $FBRX $IVVD $FMFC :1:
0 · Reply
Reacting
Reacting Apr. 9 at 4:15 PM
Ticker NXTS is squeezing!! NXTS 397k shares only!! Will NXTS be the next AIXI 2.0 ticker?! Short liquidation on NXTS right now!! $CHOW $LUD $FBRX $ANTA %
0 · Reply
LewisDaKat
LewisDaKat Apr. 9 at 4:00 PM
$FBRX Forte Biosciences Inc. (NASDAQ: FBRX) Rises Sharply in 4/9 Early Trading Session https://marketwirenews.com/stock/fbrx/news/forte-biosciences-inc-nasdaq-fbrx-rises-sharply-in-4-7062459549742409.html?utm_source=stocktwits
0 · Reply
AstralRaven
AstralRaven Apr. 9 at 4:00 PM
$ELAB $FBRX $ANTA $GIPR %100
0 · Reply
MaxDomain
MaxDomain Apr. 9 at 3:57 PM
$OMEX Save your breath, don`t buy this shitty stock, it will never go beyond 3$. Delisting coming soon $AFJK $FBRX $STAA $ANTA
2 · Reply
MaxDomain
MaxDomain Apr. 9 at 3:45 PM
$OMEX here is another pumpy dumpy stock ladies and gentlemen $AFJK $FBRX $CYCN $STAA
0 · Reply
Astrid00
Astrid00 Apr. 9 at 3:44 PM
$FBRX $PMAX $PSTV $TMDE $VWAV let’s go
0 · Reply
Reacting
Reacting Apr. 9 at 3:36 PM
$FBRX $ELAB $CLIK moving!
0 · Reply
Reacting
Reacting Apr. 9 at 3:36 PM
$GLMD $FBRX $NVDA $TSLA xS
0 · Reply
Astrid00
Astrid00 Apr. 9 at 3:36 PM
$FBRX $PMAX $PSTV $TMDE $VWAV
0 · Reply
topstockalerts
topstockalerts Apr. 9 at 3:28 PM
Top Gainers PT2 $GAME.X $YMT $GLMD $ELAB $FBRX
0 · Reply
Thsuke7
Thsuke7 Apr. 9 at 3:25 PM
$FBRX all time high! Now it goes down.
0 · Reply
Reacting
Reacting Apr. 9 at 3:10 PM
$FBRX $CLIK $SKYQ $MGRT halted?
0 · Reply
Digitalization2026
Digitalization2026 Apr. 9 at 2:39 PM
$PMAX $FBRX $PSTV $VWAV $TMDE SRXH / EMJX 🤫 👀
1 · Reply
CyberSphinx
CyberSphinx Apr. 9 at 2:25 PM
$FBRX $AFJK $RELL $GPUS +6
0 · Reply
ClassifiedTrades
ClassifiedTrades Apr. 9 at 1:41 PM
$FBRX hitting some targets $AAOI
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 9 at 1:37 PM
$FBRX Trend Play
0 · Reply
briefingcom
briefingcom Apr. 9 at 12:31 PM
$FBRX: Forte Biosciences prices offering of 5,709,936 shares of its common stock at $26.27 per share
0 · Reply
focafoca99
focafoca99 Apr. 8 at 10:23 PM
$FBRX announced a proposed underwritten public offering of common stock to fund clinical development and general corporate needs.
0 · Reply
porky1963
porky1963 Mar. 26 at 12:51 PM
$FBRX earings soon,-$0.45-0.88 my guess.
0 · Reply
Rockemsock
Rockemsock Mar. 20 at 6:49 PM
$SGLY $FBRX $CRGO $MIGI $IFRX
0 · Reply